The Biotechnology Innovation Organization (BIO) is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
BioLabs is a membership-based network of shared lab facilities located in the nation’s key biotech innovation clusters, designed exclusively for high-potential, early-stage life science companies. It offers co-working environments that pair premium, fully-equipped and supported lab and office space with unparalleled access to capital and industry partners. This fertile, supportive ecosystem allows nascent companies to shift their focus from startup operations to innovation so they can reach their scientific potential quickly and achieve business success.
BioLabs’ founding site is in Kendall Square, Cambridge, Massachusetts, with additional locations in Raleigh-Durham, North Carolina, and San Diego, California. A New York City, New York site in development.
CURE Innovation Commons
A bioscience space in Southeastern Connecticut for entrepreneurs, companies, scientists and service providers to develop their ideas and build their businesses in a vibrant and collaborative community! The CURE Innovation Commons will be housed in a former Pfizer facility in Groton, CT. Pfizer recently donated the facility to CURE Innovations, LLC, a wholly owned subsidiary of CURE. The Connecticut Bond Commission approved an allocation of $4.2 million to establish the bioscience incubator and fund the initial costs of renovations. CURE is a 501 (c)(3) not for profit organization.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute spanning three University of California campuses in the San Francisco Bay Area: UC Berkeley, UCSF, and UC Santa Cruz. QB3’s domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science. QB3@953 is located at 953 Indiana St. in the San Francisco neighborhood of Dogpatch.
A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for as many as 25 startups comprising approximately 100 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that early-stage companies need to begin laboratory operations on day one.